Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pathology · Idiopathic Granulomatous Mastitis

Pathology and Your Biopsy Report: Confirming IGM

At a Glance

Idiopathic Granulomatous Mastitis (IGM) is diagnosed by excluding other conditions like breast cancer or tuberculosis. A core needle biopsy is required to identify the hallmark "lobulocentric non-caseating granulomas" and confirm the specific pattern of inflammation in the breast.

The diagnosis of Idiopathic Granulomatous Mastitis (IGM) is what doctors call a “diagnosis of exclusion” [1]. This means that because IGM looks so much like breast cancer or rare infections on imaging, your doctor cannot confirm you have it until they have systematically ruled everything else out [2][3]. The most important tool for this process is the pathology report from your biopsy.

Why a Core Needle Biopsy is Essential

You may have had a Fine Needle Aspiration (FNA) first, which uses a very thin needle to pull out cells. However, for IGM, a Core Needle Biopsy (CNB) is required [4]. Unlike an FNA, which only looks at individual cells, a core needle takes a small “core” of tissue, allowing the pathologist to see the actual structure of the breast and how the inflammation is organized [5][6]. This structural view is necessary to see the hallmark patterns of IGM.

Decoding Your Report: “Lobulocentric Granulomas”

When you read your report, you will likely see the term lobulocentric non-caseating granulomatous inflammation [7]. Here is what that means in plain language:

  • Lobulocentric: The inflammation is centered specifically in the lobules, the milk-producing glands of the breast [7].
  • Granulomatous: Your immune system has formed granulomas, which are tiny, organized clumps of immune cells (macrophages) sent to wall off something the body perceives as foreign [7][8].
  • Non-caseating: This is a vital term. “Caseating” means the center of the inflammation looks like cheese, a common sign of tuberculosis (TB). Non-caseating means that “cheesy” death of tissue is absent, which helps rule out TB [9].

Ruling Out Tuberculosis (TB) and Fungi

Breast TB is rare but can look identical to IGM. Pathologists use specific tests to tell them apart:

  • Caseous Necrosis: As mentioned above, the presence of this tissue death pattern usually points to TB, while its absence points to IGM [9].
  • AFB/ZN Stains: Pathologists use a special stain called Acid-Fast Bacilli (AFB) or Ziehl-Neelsen (ZN). If these are “negative,” it means they did not find the bacteria that cause TB [9].
  • Fungal Stains: Additionally, rare fungal infections can also cause granulomas, so your pathologist should perform stains (like GMS or PAS) to rule these out as well [1].

Testing for Corynebacterium

If your report mentions Cystic Neutrophilic Granulomatous Mastitis (CNGM), it suggests a specific subtype often linked to the bacterium Corynebacterium kroppenstedtii [10][11]. These bacteria are “fastidious,” meaning they are very difficult to grow in standard lab cultures [12]. You may want to ask your doctor if they performed a Gram stain or advanced testing like 16S rRNA PCR to look for this specific organism [12][13].

Your Pathology Completeness Checklist

Review your report to ensure it contains these key elements. If any are missing, you have the right to request that your doctor ask the pathologist for an addendum.

  1. No Malignancy: A clear statement that no cancer cells were found [2].
  2. Granulomas Present: Specifically mentioning “lobulocentric” or “granulomatous inflammation” [7].
  3. Negative for TB: Must state that AFB or ZN stains were performed and were negative [9].
  4. Negative for Fungi: Often listed as a negative GMS or PAS stain to rule out fungal infections [1].
  5. Absence of Necrosis: Should specify “non-caseating granulomas” or state that caseous necrosis is absent [9].

Return to Home

Common questions in this guide

Why do I need a core needle biopsy instead of a fine needle aspiration for IGM?
A core needle biopsy takes a small piece of tissue rather than just individual cells. This allows the pathologist to see the structure of the breast and identify the organized inflammation patterns required to diagnose idiopathic granulomatous mastitis.
What does lobulocentric non-caseating granulomatous inflammation mean?
This means your immune system has formed small clumps of cells (granulomas) centered around the milk-producing glands (lobules) of your breast. "Non-caseating" means the tissue lacks the cheese-like appearance typically seen in tuberculosis infections.
Why does my pathology report mention stains for TB and fungi?
Idiopathic granulomatous mastitis is a diagnosis of exclusion. Pathologists must use specific tests, like AFB and fungal stains, to ensure your symptoms are not actually caused by rare breast infections like tuberculosis or fungi.
What is Cystic Neutrophilic Granulomatous Mastitis (CNGM)?
CNGM is a specific subtype of granulomatous mastitis that is often linked to an infection by Corynebacterium. If your report mentions this pattern, your doctor may need to perform advanced testing to look for this specific, hard-to-grow bacteria.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you walk me through my pathology report and show me where it rules out malignancy?
  2. 2.Was a Ziehl-Neelsen (ZN) stain or PCR performed to rule out tuberculosis?
  3. 3.Does the report mention 'cystic neutrophilic' patterns or 'lipid vacuoles,' and if so, should we test for Corynebacterium?
  4. 4.Were fungal stains like GMS or PAS performed to rule out fungal infections?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    A successful case of etanercept used for idiopathic granulomatous mastitis.

    Wang ST, Lin JC, Li CF, Lee YH

    The breast journal 2019; (25(2)):343-345 doi:10.1111/tbj.13219.

    PMID: 30790374
  2. 2

    Magnetic resonance imaging findings for inflammatory mastitis of unknown etiology.

    Macedo M, Ganau S, Úbeda B, et al.

    Radiologia 2024; (66(5)):410-418 doi:10.1016/j.rxeng.2023.02.006.

    PMID: 39426810
  3. 3

    A single center experience with a rare clinical entity of idiopathic granulomatous mastitis: Case series and review of the literature.

    Musleh A, Shrateh ON, Ishtaya N, et al.

    International journal of surgery case reports 2024; (115()):109232 doi:10.1016/j.ijscr.2024.109232.

    PMID: 38217923
  4. 4

    Comparison of Diagnostic Yield Between Fine Needle Aspiration Cytology and Core Needle Biopsy in the Diagnosis of Thyroid Nodule.

    Lee Y, Ban MJ, Kim DH, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(20)) doi:10.3390/diagnostics15202566.

    PMID: 41153239
  5. 5

    Comparative Study of Core Needle Biopsy and Fine Needle Aspiration Cytology in Palpable Breast Lumps: Scenario in Developing Nations.

    Tikku G, Umap P

    Turk patoloji dergisi 2016; (32(1)):1-7 doi:10.5146/tjpath.2015.01335.

    PMID: 26832175
  6. 6

    Preoperative ultrasound guided percutaneous axillary biopsy in breast cancer patients: fine needle aspiration cytology versus core biopsy.

    Zosimas D, Lykoudis PM, Vashisht R

    Annali italiani di chirurgia 2016; (87()):509-516.

    PMID: 27594687
  7. 7

    Assertive clinical practice in managing patients with idiopathic granulomatous mastitis: Review of literature.

    Alsaleh N

    Annals of medicine and surgery (2012) 2021; (70()):102792 doi:10.1016/j.amsu.2021.102792.

    PMID: 34691410
  8. 8

    Pathological manifestations of granulomatous lobular mastitis.

    Cui L, Sun C, Guo J, et al.

    Frontiers in medicine 2024; (11()):1326587 doi:10.3389/fmed.2024.1326587.

    PMID: 38371511
  9. 9

    Cytomorphological Spectrum of Granulomatous Mastitis: A Study of 33 Cases.

    Chandanwale S, Naragude P, Shetty A, et al.

    European journal of breast health 2020; (16(2)):146-151 doi:10.5152/ejbh.2020.5185.

    PMID: 32285037
  10. 10

    Cystic neutrophilic granulomatous mastitis: A clinicopathologic study of a distinct entity with supporting evidence of a role for Corynebacterium-targeted therapy.

    Shoyele O, Vidhun R, Dodge J, et al.

    Annals of diagnostic pathology 2018; (37()):51-56 doi:10.1016/j.anndiagpath.2018.08.005.

    PMID: 30248572
  11. 11

    Idiopathic granulomatous mastitis: a 5-year retrospective review of cases in a tertiary centre in Dublin, Ireland.

    Houlihan E, Ryan K, Mannion J, et al.

    Journal of clinical pathology 2024; (77(12)):835-841 doi:10.1136/jcp-2023-209028.

    PMID: 37699697
  12. 12

    Whole genome sequence of Corynebacterium kroppenstedtii isolated from a case of recurrent granulomatous mastitis.

    Tan C, Lu FI, Aftanas P, et al.

    IDCases 2021; (23()):e01034 doi:10.1016/j.idcr.2020.e01034.

    PMID: 33489755
  13. 13

    Not always a commensal: A case of mastitis by Corynebacterium amycolatum.

    Borde K, Rao V, Shah M, et al.

    IDCases 2020; (20()):e00728 doi:10.1016/j.idcr.2020.e00728.

    PMID: 32140414

This page is designed to help you understand your IGM pathology report for educational purposes only. Always consult your pathologist and breast specialist to interpret your specific biopsy results.

Get notified when new evidence is published on Granulomatous mastitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.